2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Human T-lymphotropic Virus 1 Infection in 1 studies
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grassi, F | 1 |
| Guimarães Corrêa, AB | 1 |
| Mascarenhas, RE | 1 |
| Galvão, B | 1 |
| Séon-Méniel, B | 1 |
| Schmidt, F | 1 |
| Franck, X | 1 |
| Hocquemiller, R | 1 |
| Figadère, B | 1 |
| Fournet, A | 1 |
1 other study available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Human T-lymphotropic Virus 1 Infection
| Article | Year |
|---|---|
Quinoline compounds decrease in vitro spontaneous proliferation of peripheral blood mononuclear cells (PBMC) from human T-cell lymphotropic virus (HTLV) type-1-infected patients.
Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; HTLV-I Infect | 2008 |